185
Participants
Start Date
August 31, 2008
Primary Completion Date
April 30, 2011
Study Completion Date
May 31, 2011
NA-1
single intravenous dose of 2.6 mg/kg of NA-1 administered as a 10-minute infusion
Placebo
single intravenous dose of 2.6 mg/kg of placebo administered as a 10-minute infusion
Barrow Neurological Institute, Phoenix
Stanford University Medical Center, Stanford
Oregon Health and Science University, Portland
Foothills Medical Centre, Calgary
University of Alberta Hospital, Edmonton
QEII Health Sciences Centre - Halifax Infirmary, Halifax
Hamilton Health Sciences General Site, Hamilton
London Health Sciences Centre, London
The Ottawa Hospital - Civic Campus, Ottawa
St. Michael's Hospital, Toronto
Toronto Western Hospital, Toronto
Hôpital Notre-Dame du Centre Hospitalier de l'Université de Montréal (CHUM), Montreal
Hopital de l'Enfant Jesus, Québec
Royal University Hospital, Saskatoon
Collaborators (1)
Arbor Vita Corporation
INDUSTRY
NoNO Inc.
INDUSTRY